# Axillary Lymph Node Dissection Versus no Dissection in Breast Cancer With Positive Sentinel Lymph Node

> **NCT01796444** · PHASE3 · WITHDRAWN · sponsor: **Shandong Cancer Hospital and Institute**

## Conditions studied

- Breast Cancer

## Interventions

- **PROCEDURE:** Sentinel Lymph Node Biopsy
- **PROCEDURE:** Intraoperative Pathological Examination
- **PROCEDURE:** Axillary Lymph Node Dissection
- **PROCEDURE:** Pathological Evaluation
- **DRUG:** Adjuvant Systemic Therapy
- **RADIATION:** Radiation Therapy

## Key facts

- **NCT ID:** NCT01796444
- **Lead sponsor:** Shandong Cancer Hospital and Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2013-01
- **Primary completion:** 2025-12
- **Final completion:** 2026-06
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2018-04-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01796444

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01796444, "Axillary Lymph Node Dissection Versus no Dissection in Breast Cancer With Positive Sentinel Lymph Node". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01796444. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*